newsfilter
← Latest News
GlobeNewswire·

PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference

  • PolyPid Ltd. (NASDAQ: PYPD) management will attend the Craig-Hallum 23rd Annual Institutional Investor Conference on Thursday, May 28, 2026, at the Depot Renaissance Hotel in Minneapolis, MN.
  • Investors seeking meetings should contact their Craig Hallum representative directly.
  • The company develops long-acting, controlled-release drugs targeting surgical care, metabolic diseases, & other areas.
  • PolyPid's lead product, D-PLEX₁₀₀, met all primary & key secondary endpoints in the Phase 3 SHIELD II trial for preventing surgical site infections.
  • Company contact is Ori Warshavsky at 908-858-5995 or IR@Polypid.com.
  • Investor Relations contact is handled by Arx Investor Relations at polypid@arxhq.com.